Renalytix Enterprise Value Over E B I T D A from 2010 to 2024
| RNLX Stock | USD 0.15 0.01 6.25% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (1.09) | Current Value (1.14) | Quarterly Volatility 679.46210455 |
Check Renalytix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Renalytix's main balance sheet or income statement drivers, such as Interest Expense of 4 K, Other Operating Expenses of 29.8 M or Tax Provision of 4.2 K, as well as many indicators such as Price To Sales Ratio of 11.26, Dividend Yield of 0.0 or Days Sales Outstanding of 82.42. Renalytix financial statements analysis is a perfect complement when working with Renalytix Valuation or Volatility modules.
Renalytix | Enterprise Value Over E B I T D A |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.